Actively Recruiting
Study to Validate a Formula Calculating Post-Filter Hematocrit Compared to Measured Values in Patients on Continuous Renal Replacement Therapy
Led by Gwyndolyn M. Radford · Updated on 2025-12-19
20
Participants Needed
1
Research Sites
6 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating a new formula to calculate post-filter hematocrit in patients undergoing continuous renal replacement therapy CRRT. This study aims to validate whether the calculated post-filter hematocrit matches the values measured directly from blood samples. Filter clotting is a significant complication during CRRT, causing blood loss and treatment challenges, so finding accurate markers to predict clotting risk is important. Participants will have blood samples collected from their CRRT machines post-filter lines at various times and flow rates. The study compares the hematocrit calculated by the formula HCTpostHCTpreFFHCTpre-11 to measured hematocrit values from these samples. All participants receive the same procedure of both calculation and measurement. The study is cross-sectional, with participation lasting generally no longer than one day. During the study, four post-filter blood samples are collected over about 40 minutes. Researchers will analyze agreement between measured and calculated hematocrit and explore how CRRT settings and patient factors affect differences. There are no additional treatments or follow-up visits. Participation ends after the final blood draw, and safety monitoring is not specifically mentioned due to the short, observational nature of the procedure.
CONDITIONS
Brief Title
Post-Filter Hematocrit
Research Team
G
Gwyndolyn M Radford, MD
B
Benjamin R Griffin, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
